27 November 2017
A joint team between the Lausanne CHUV and Harvard American University paves the way for a new neuroprotective treatment for schizophrenia. Three questions to Kim Do, head of the Center for Psychiatric Neuroscience at the CHUV-Prilly: You have successfully tested Read more…
